This bill clarifies that Medicare must cover fully implanted active middle ear hearing devices as prosthetics, not as hearing aids. It requires the Centers for Medicare & Medicaid Services (CMS) to update its rules within 60 days of the bill's enactment to remove these devices from Medicare's hearing aid coverage exclusion. This directly affects Medicare beneficiaries who rely on these specific implanted devices for hearing. The change means these devices will now be covered under Medicare's prosthetic benefits, not excluded under hearing aid rules, without altering existing coverage for other hearing aids.
This bill removes a requirement for ambulatory surgical centers participating in Medicare to report the COVID-19 vaccination status of their healthcare workers. Specifically, it directs the Secretary of Health and Human Services to revise Medicare regulations (42 CFR §§ 416.300-416.330) within 45 days of enactment to eliminate this reporting mandate. The change directly affects ambulatory surgical centers that receive Medicare funding, removing a specific administrative burden related to employee vaccination data. The bill focuses solely on modifying existing reporting rules, with no new funding or program requirements.
This bill changes the negotiation period for small-molecule drugs under the federal Drug Price Negotiation Program from 7 years to 11 years, matching the existing 11-year period for biologic drugs. It directly affects drug manufacturers participating in the program by extending the timeframe for price negotiations with the government. The amendment applies to all small-molecule drugs covered under the program, creating a uniform negotiation timeline for both drug types. The change takes effect as if included in the Inflation Reduction Act of 2022.
HR 7142 (Alternatives to PAIN Act) requires Medicare Part D plans to cover non-opioid pain management drugs with no deductible and at the lowest copay level starting in 2025. It defines "qualifying non-opioid drugs" as FDA-approved medications that don’t act on opioid receptors (like certain NSAIDs or nerve pain treatments), excluding opioids and schedule I-III drugs. The bill prohibits Medicare plans from forcing patients to try opioids first (step therapy) or requiring prior approval for these non-opioid options. It directly affects Medicare beneficiaries needing pain management, especially those seeking alternatives to opioids for post-surgical or acute pain. The policy change aims to improve access to non-addictive pain treatments while preserving doctors' authority to prescribe medically appropriate care.
HR 6909 establishes a presumption that cobalt refined in China (PRC) is made with forced or child labor, barring such cobalt imports under U.S. customs law (Section 307 of the Tariff Act). It targets cobalt from China-controlled mines in the Democratic Republic of Congo (DRC), where forced labor and child labor are documented in artisanal mining. Importers must prove cobalt isn’t from China to avoid seizure, and the bill requires U.S. Customs to trace supply chains and report on enforcement. The law also mandates annual certification that federal vehicles contain no cobalt linked to forced labor in the DRC or Xinjiang.
HR 6755 (Supporting Healthy Pregnancy Act) requires states to establish child support obligations for biological fathers to pay at least 50% of a mother's reasonable out-of-pocket medical expenses related to pregnancy and delivery, upon her request. This applies to costs like copays, insurance deductibles, and other direct expenses incurred during pregnancy and birth. The bill explicitly excludes abortion-related expenses from this requirement, defining abortion as intentional pregnancy termination except for medical reasons like ectopic pregnancy or preserving life/health. States must implement this provision within one year of enactment, with possible extensions if state legislation needs updating.
The Preserving Seniors’ Access to Physicians Act of 2023 increases the Medicare payment adjustment rate for physicians from 1.25% to 4.62%, directly affecting doctors who treat Medicare patients (primarily seniors). It also reduces the funding for the Medicaid improvement fund from $5,796,117,810 to $3,973,117,810. These changes impact Medicare providers and Medicaid programs, with the Medicare adjustment aimed at supporting physicians adjusting to payment changes. The bill does not specify how the Medicaid funding reduction relates to its stated goal of preserving seniors' access to physicians.
This bill updates Medicare's physician fee schedule to better align with current healthcare costs and support providers. It extends a key deadline for geographic payment adjustments from 2024 to 2025, increases the rate for payment adjustments from 1.25% to 3%, and extends incentive payments for doctors in alternative payment models (APMs) through 2026. For 2026, it imposes payment reductions (34% for 4-6 years in APMs, 67% for 7+ years) but allows exceptions if providers increased their financial risk compared to 2025. The bill also raises Medicare's budget neutrality threshold to $53 million in 2025 and requires regular updates to cost data (like staff wages and equipment prices) every five years. These changes directly affect Medicare-participating physicians, especially those in APMs, by altering payment calculations and incentives.
This bill protects religious child welfare providers from losing government contracts or funding if they refuse to provide services conflicting with their sincerely held religious beliefs (e.g., certain foster care or adoption placements). It prohibits states and federal agencies from denying contracts, licenses, or renewals for this reason, and allows providers to sue for violations with recovery of damages and legal fees. States violating the law risk losing 15% of federal child welfare funding. The law applies to all federally funded child welfare services, including foster care, adoption support, and family preservation programs.
This bill prohibits health insurance plans from charging healthcare providers fees for electronic payments (EFTs) and payment advice transactions. It directly affects doctors, hospitals, and clinics that receive electronic payments from health plans by banning any charges, including withholdings, for these transactions. The law, effective January 1, 2024, amends the Social Security Act to require health plans to cover these costs themselves, eliminating fees for providers.
This bill updates Medicare physician payment rules to improve stability and accuracy. It raises the budget neutrality threshold from $20 million (pre-2025) to $53 million in 2025, with annual indexing after 2026, to prevent excessive payment adjustments. The bill requires the Medicare program to correct budget neutrality payments based on actual service utilization data (not estimates) starting in 2025, and mandates updating direct cost inputs (like staff wages and equipment prices) every 5 years. It also caps annual changes to the physician payment conversion factor at 2.5% to limit sudden payment shifts, directly affecting Medicare physicians and healthcare providers receiving these payments.
HR 6344, the Simon Crosier Act, requires Medicare and Medicaid providers to establish written policies for do-not-resuscitate (DNR) orders involving unemancipated minors (under 18 without legal independence). It mandates that providers must inform at least one parent or legal guardian in person or by phone (with 72 hours of effort) before considering a DNR, allow parents/guardians to refuse consent, and prohibit overriding parental objections to life-sustaining treatment. The bill also requires providers to continue life-sustaining care for 15 days if a parent requests a transfer and explicitly prohibits using disability as the sole basis for DNR decisions. These requirements apply to all Medicare/Medicaid-covered facilities and directly affect minors, their parents, and healthcare providers.
